Advertisement

Diagnostic Techniques in Clinical Practice – OCT, FA, Ultrasound

  • Keye Wong
Chapter

Abstract

If one follows the assumption that management of patients with diabetic retinopathy begins with an appropriate history and clinical examination then the purpose of ancillary diagnostic testing should be to add value to evaluation of the patient. Examples of such value may be to provide patient education to gain compliance with treatment recommendations (blood sugar control); to decide when additional intervention is beneficial either at baseline (detection of diabetic macular edema) or follow-up (response of diabetic macular edema to therapy); and to help establish prognosis such that appropriate follow-up schedules can be mutually agreed upon. In a research setting, there are additional purposes for ancillary testing but the emphasis in this chapter is on clinical care of patients with diabetic retinopathy.

Keywords

Optical Coherence Tomography Diabetic Retinopathy Macular Edema Fluorescein Angiography Diabetic Macular Edema 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Hee MR, Puliafito CA, Wong C, et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol. 1995;113:1019–1029.PubMedGoogle Scholar
  2. 2.
    Tangelder GJ, Van der Heidje RG, Polak BC, et al. Precision and reliability of retinal thickness measurements in foveal and extrafoveal areas of healthy and diabetic eyes. IOVS. 208;49:2627–2634.Google Scholar
  3. 3.
    Diabetic Retinopathy Clinical Research Network. Reproducability of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology. 2007;114:1520–1525.CrossRefGoogle Scholar
  4. 4.
    Virgilia G, Menchini F, Dimastrogiovanni AF, et al. Optical coherence tomography versus stereo fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review. IOVS. 2007;48:4963–4973.Google Scholar
  5. 5.
    Browning DJ, Glassman AR, Aiello LP, et al. Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology. 2008;115:1366–1371.CrossRefPubMedGoogle Scholar
  6. 6.
    Degenring RF, Aschmoneit I, Kamppeter B, et al. Optical coherence tomography and confocal scanning laser tomography for assessment of macular edema. Am J Ophthalmol. 2004;138:354–162.Google Scholar
  7. 7.
    Hee MR, Pulafito CA, Duker JS, et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology. 1998;105:360–370.CrossRefPubMedGoogle Scholar
  8. 8.
    Bressler NM, Edwards AR, Antoszyk AN, et al. Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. Am J Ophthalmol. 2008;145:894–901.CrossRefPubMedGoogle Scholar
  9. 9.
    Cunningham ET Jr., Adamis AP, Altaweel M, et al. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology. 2005;112:1747–1757.CrossRefPubMedGoogle Scholar
  10. 10.
    Chun DW, Heier JS, Topping TM, et al. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology. 2006;113:1706–1712.CrossRefPubMedGoogle Scholar
  11. 11.
    Shimura M, Nakazawa T, Yasuda K, et al. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema. Am J Ophthalmol. 2008;145:854–861.CrossRefPubMedGoogle Scholar
  12. 12.
    Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: ETDRS Report Number 1. Arch Ophthalmol. 1985;103:1796–1806.Google Scholar
  13. 13.
    Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology. 2008;115:1447–1459.CrossRefGoogle Scholar
  14. 14.
    Bressler NM, Edwards AR, Antoszyk AN, et al. Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. Am J Ophthalmol. 2008;145:894–901.CrossRefPubMedGoogle Scholar
  15. 15.
    Davis MD, Bressler SB, Aiello LP Jr, et al. Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. IOVS. 2008;49:1745–1752.Google Scholar
  16. 16.
    Brown JC, Solomon SD, Bressler SB, et al. Detection of diabetic foveal edema: Contact lens biomicroscopy compared with optical coherence tomography. Arch Ophthalmol. 2004;122:330–335.CrossRefPubMedGoogle Scholar
  17. 17.
    Browning DJ, McOwen MD, Bowen RM Jr, et al. Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology. 2004;111:712–715.CrossRefPubMedGoogle Scholar
  18. 18.
    Diabetic Retinopathy Clinical Research Network. Subclinical Diabetic Macular Edema Study. http://public.drcr.net/DRCRnetstudies/studies/ProtocolG_subclinical/ProtGInfo.html. Accessed January 17, 2009.
  19. 19.
    Forooghian F, Cukras C, Meyerle CB, et al. Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. IOVS. 2008;49:4290–4296.Google Scholar
  20. 20.
    Davis MD, Bressler SB, Aiello LP Jr, et al. Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. IOVS. 2008;49:1745–1752.Google Scholar
  21. 21.
    Diabetic Retinopathy Clinical Research Network. The course of response to focal photocoagulation for diabetic macular edema. http:www.drcr.net. Accessed January 17, 2009.
  22. 22.
    Diabetic Retinopathy Clinical Research Network. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology. 2007;114:525–536.CrossRefGoogle Scholar
  23. 23.
    Browning DJ & Fraser CM. The predictive value of patient and eye characteristics on the course of subclinical diabetic macular edema. Am J Ophthalmol. 2008;145:149–154.CrossRefPubMedGoogle Scholar
  24. 24.
    Browning DJ, Fraser CM, Propst BW. The variation in optical coherence tomography-measured macular thickness in diabetic eyes without clinical macular edema. Am J Ophthalmol. 2008;145:889–893.CrossRefPubMedGoogle Scholar
  25. 25.
    Diabetic Retinopathy Clinical Research Network. An observational study of the development of diabetic macular edema following scatter laser photocoagulation. http://public.drcr.net/DRCRnetstudies/studies/ProtocolF_prp/ProtFInfo.html. Accessed January 17, 2009.
  26. 26.
    Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of diabetic retinopathy study (DRS) findings. DRS Report #8. Ophthalmology. 1981;88:583–600.Google Scholar
  27. 27.
    Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report no. 9. Ophthalmology. 1991;98:766–785.Google Scholar
  28. 28.
    Zacks DN, Johnson MW. Combined intravitreal injection of triamcinolone acetonide and panretinal photocoagulation for concomitant diabetic macular edema and proliferative diabetic retinopathy. Retina. 2005;25:35–140.Google Scholar
  29. 29.
    Bandello F, Polito A, Pognuz DR, et al. Triamcinolone as adjunctive treatment to laser photocoagulation to laser panretinal photocoagulation for proliferative diabetic retinopathy. Arch Ophthalmol. 2006;124:643–650.CrossRefPubMedGoogle Scholar
  30. 30.
    Otani T, Kishi S, Maruyama Y. Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol. 1999;127:688–693.CrossRefPubMedGoogle Scholar
  31. 31.
    Kim BY, Smith SD, Kaiser PK. Optical coherence tomographic patterns of diabetic macular edema. Am J Ophthalmol. 2006;142:405–412.CrossRefPubMedGoogle Scholar
  32. 32.
    Kang SW, Park CY, Ham DI. The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema. Am J Ophthalmol. 2004;137:313–322.CrossRefPubMedGoogle Scholar
  33. 33.
    Diabetic Retinopathy Clinical Research Network. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology. 2007;114:525–536.CrossRefGoogle Scholar
  34. 34.
    Kim BY, Smith SD, Kaiser PK. Optical coherence tomographic patterns of diabetic macular edema. Am J Ophthalmol. 2006;142:405–412.CrossRefPubMedGoogle Scholar
  35. 35.
    Early Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline. ETDRS report no. 19. Arch Ophthalmol. 1995;113:1144–1155.Google Scholar
  36. 36.
    Lewis H. Abrams GW, Blumenkranz MS, et al. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology. 1992;99:753–759.PubMedGoogle Scholar
  37. 37.
    Lewis H, Abrams GW, Blumenkranz MS, et al. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology. 1992;99:753–759.PubMedGoogle Scholar
  38. 38.
    Diabetic Retinopathy Clinical Research Network. Evaluation of Vitrectomy for Diabetic Macular Edema. http://public.drcr.net/DRCRnetstudies/studies/ProtocolD_vitrectomy/ProtDInfo.html. Accessed January 17, 2009.
  39. 39.
    Browning DJ, Glassman AR, Aiello LP, et al. Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology. 2008;115:1366–1371.CrossRefPubMedGoogle Scholar
  40. 40.
    Guan K, Hudson C, Flanagan JG. Comparison of Heidelberg retinal tomography II and retinal thickness analyzer in assessment of diabetic macular edema. IOVS. 2004;45:610–616.Google Scholar
  41. 41.
    Strom C, Sander B. Comparison of objective retinal thickness analysis and subjective stereo fundus photography in diabetic macular edema. IOVS. 2004;45:1450–1455.Google Scholar
  42. 42.
    Neubauer AS, Priglinger S, Ullrich S, et al. Comparison of foveal thickness measured with the retinal thickness analyzer and optical coherence tomography. Retina. 2001;21:596–601.CrossRefPubMedGoogle Scholar
  43. 43.
    Vujosevic S, Midena E, Pilotto E, et al. Diabetic macular edema: Correlation between microperimetry and optical coherence tomography findings. IOVS. 2006;47:3044–1051.Google Scholar
  44. 44.
    Carpineto P, Ciancaglini M, Di Antonio L, et al. Fundus microperimetry patterns of fixation in type 2 diabetic patients with diffuse macular edema. Retina. 2007;27:21–29.CrossRefPubMedGoogle Scholar
  45. 45.
    ETDRS Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS Report # 12. Ophthalmology. 1991;98:823–833.Google Scholar
  46. 46.
    Whited JD. Accuracy and reliability of teleophthalmology for diagnosing diabetic retinopathy and macular edema: A review of the literature. Diabetes Technol Ther. 2006;8:102–111.CrossRefPubMedGoogle Scholar
  47. 47.
    Tennant MT, Greve MD, Rudnisky CJ, et al. Identification of diabetic retinopathy by stereoscopic digital imaging via teleophthalmology: a comparison to slide film. Can J Ophthalmol. 2001;36:187–196.PubMedGoogle Scholar
  48. 48.
    Rudnisky CJ, Tennant MT, Weis E, et al. Web-based grading of compressed stereoscopic digital photography versus standard slide-film photography for the diagnosis of diabetic retinopathy. Ophthalmology. 2007;114:1748–1754.CrossRefPubMedGoogle Scholar
  49. 49.
    Lim JI, LaBree L, Nichols T, et al. A comparison of digital nonmydriatic fundus imaging with standard 35-millimeter slides for diabetic retinopathy. Ophthalmology. 2000;107:866–870.CrossRefPubMedGoogle Scholar
  50. 50.
    Gass JD. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. 4th ed. St. Louis: Mosby-Year Book; 1997.Google Scholar
  51. 51.
    Ryan SJ ed. Retina: Volume Two Medical Retina. 4th ed. St. Louis: Mosby; 2006.Google Scholar
  52. 52.
    Flocks M. Miller J, Chao P. Retinal circulation time with the aid of fundus cinephotography. Am J Ophthalmol. 1959;48:3–10.PubMedGoogle Scholar
  53. 53.
    MacLean Al, Maumenee AE. Hemangioma of he choroid. Am J Ophthalmol. 1960;50:3–11.PubMedGoogle Scholar
  54. 54.
    Novotny HR, Alvis DL. A method of photographing fluorescence in circulating blood in the human retina. Circulation. 1961;24:82–86.PubMedGoogle Scholar
  55. 55.
    Aiello L, Berrocal J. David M, et al. The diabetic retinopathy study. Arch Ophthalmol. 1973;90:347–348.Google Scholar
  56. 56.
    Early Treatment Diabetic Retinopathy Study Research Group. Classification of diabetic retinopathy from fluorescein angiograms: ETDRS report no. 11. Ophthalmology. 1991;98:807–822.Google Scholar
  57. 57.
    Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. ETDRS report no. 2. Ophthalmology. 1987;94:761–774.Google Scholar
  58. 58.
    Diabetic Retinopathy Study Research Group. Indications for photocoagulation treatment of diabetic retinopathy. DRS report no. 14. Int Ophthalmol Clin. 1987;27:239–253.Google Scholar
  59. 59.
    Diabetic Retinopathy Study Research Group. Four risk factors for severe visual loss in diabetic retinopathy: the third report from the diabetic retinopathy study. Arch Ophthalmol. 1979;97:654–655.Google Scholar
  60. 60.
    Browning DJ, Altaweel MM, Bressler NM, et al. Diabetic macular edema: what is focal and what is diffuse? Am J Ophthalmol. 2008;146:649–655.CrossRefPubMedGoogle Scholar
  61. 61.
  62. 62.
    Diabetic Retinopathy Clinical Research Network Writing Group. Comparison of the modified early treatment diabetic retinopathy study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol. 2007;125:469–480.CrossRefGoogle Scholar
  63. 63.
    Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology. 2008;115:1447–1459.CrossRefGoogle Scholar
  64. 64.
    Abu El Asrar AM, Morse PH. Laser photocoagulation control of diabetic macular edema without fluorescein angiography. Br J Ophthalmol. 1991;75;97–99.Google Scholar
  65. 65.
    Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480–1487.CrossRefPubMedGoogle Scholar
  66. 66.
    Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema. http://clinicaltrials.gov/ct2/show/NCT00387582. Accessed January 18, 2009.
  67. 67.
    Diabetic Retinopathy Clinical Research Network. Intravitreal Ranibuzumab or Triamcinolone Acetonide in Combination with Laser Photocoagulation for Diabetic Macular Edema. http://public.drcr.net/DRCRnetstudies/studies/ProtocolI_lrtdme/ProtIInfo.html. Accessed January 18, 2009.
  68. 68.
    Diabetic Retinopathy Clinical Research Network. Intravitreal Ranibuzumab or Triamcinolone Acetonide in as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy. http://public.drcr.net/DRCRnetstudies/studies/ProtocolJ_lrtpdr/ProtJInfo.html. Accessed January 18, 2009.
  69. 69.
    Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984;98:271–282.Google Scholar
  70. 70.
    Early Treatment Diabetic Retinopathy Study Research Group. Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report no. 11. Ophthalmology. 1991;98:807–822.Google Scholar
  71. 71.
    Pendergast SD, Hassan TS, Williams GA, et al. Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol. 2000;130:178–186.CrossRefPubMedGoogle Scholar
  72. 72.
    Chung EJ, Roh MI, Kwon OW, et al. Effects of macular ischemia on the outcome of bevacizumab therapy on diabetic macular edema. Retina. 2008;28:957–963.CrossRefPubMedGoogle Scholar
  73. 73.
    Early Treatment Diabetic Retinopathy Study Research Group. Fluorescein angiographic risk factors for progression of diabetic retinopathy. ETDRS report no. 13. Ophthalmology. 1991;98:834–840.Google Scholar
  74. 74.
    Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480–1487.CrossRefPubMedGoogle Scholar
  75. 75.
    Hamanaka T, Akabane N, Yajima T, et al. Retinal ischemia and angle neovascularization in proliferative diabetic retinopathy. Am J Ophthalmol. 2001;132:648–658.CrossRefPubMedGoogle Scholar
  76. 76.
    Brancato R, Bandello F, Latanzio R eds. Atlas of Iris Fluorescein Angiography. Milano, Amsterdam, New York: Kugler, Ghendini; 1995.Google Scholar
  77. 77.
    Bandello F, Brancato R, Lattanzio R, et al. Biomicroscopy versus fluorescein angiography in the detection of diabetic iridopathy. Graefes Arch Clin Exp Ophthalmol. 1993;231:444–448.CrossRefPubMedGoogle Scholar
  78. 78.
    Green RL & Byrne SF. Diagnostic ophthalmic ultrasound. In: Ryan SJ, ed. Retina. 4th ed. Philadelphia: Elsevier Mosby; 2006.Google Scholar
  79. 79.
    Lewis H, Abrams GW, Williams GA. Anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy. Am J Ophthalmol. 1987;104:607–613.PubMedGoogle Scholar
  80. 80.
    Han DP, Lewandowski M, Mieler WF. Echographic diagnosis of anterior hyaloidal fibrovascular proliferation. Arch Ophthalmol. 1991;109:842–846.PubMedGoogle Scholar
  81. 81.
    Garcia JP & Rosen RB. Anterior segment imaging: optical coherence tomography versus ultrasound biomicroscopy. Ophthalmic Surg Laser Imag. 2008;39:476–484.CrossRefGoogle Scholar
  82. 82.
    Bhende M, Agraharam SG, Gopal L, et al. Ultrasound biomicroscopy of sclerotomy sites after pars plana vitrectomy for diabetic vitreous hemorrhage. Ophthalmology. 2000;107:1720–1736.CrossRefGoogle Scholar
  83. 83.
    Palmowski AM, Sutter EE, Bearse MA, et al. Mapping of retinal function in diabetic retinopathy using the multifocal electroretinogram. IOVS. 1997;38:2586–2596.Google Scholar
  84. 84.
    NG JS, Bearse MA, Schneck ME, et al. Local diabetic retinopathy prediction by multifocal ERG delays over 3 years. IOVS. 2008;49:1622–1628.Google Scholar
  85. 85.
    Lobo CL, Bernardes RC, Figueira JP, et al. Three-year follow-up of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy. Arch Ophthalmol. 2004;122:211–217.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.University of South FloridaSarasotaUSA

Personalised recommendations